# Lupin Limited (LUPIN)

> LUPIN closed at ₹2,011.00 on 30 Oct 2026, trailing P/E 16.6, market cap ₹91,953 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Lupin Limited (NSE: LUPIN) closed at ₹2,011.00 on 30 Oct 2026, +3.7% over one year, against a 52-week range of ₹1,892.90 – ₹2,529.50.

In the quarter ended 30 Jun 2026 (consolidated, filed 6 Aug 2026) it reported revenue of ₹8,277 cr and net profit of ₹1,415 cr, a 17.1% net margin; revenue grew 32.0% and profit grew 42.5% year on year.

On four consecutive filed quarters its trailing P/E is 16.6; since 15 May 2025 its own P/E has ranged from 15.7 to 30.8 (median 26.3), and today's reading is higher than 3% of those 361 trading days.

From the balance sheet dated 31 Mar 2026: return on equity 25.2%, ROCE 33.1%, debt-to-equity 0.26, Piotroski F-score 8 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 64% of 63 sector peers; PBT margin higher than 70% of 63 sector peers; ROE higher than 87% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹2,011.00 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -4.3% / -12.4% / +3.7% |
| 52-week low – high | ₹1,892.90 – ₹2,529.50 |
| Market capitalisation | ₹91,953 cr |
| Trailing P/E | 16.6 |
| Price / book | 4.10 |
| EV / EBITDA | 9.9 |
| Earnings yield | 6.0% |
| TTM EPS | ₹120.91 |
| TTM net profit | ₹5,529 cr |
| Quarter revenue | ₹8,277 cr |
| Quarter net profit | ₹1,415 cr |
| Net margin | 17.1% |
| Revenue growth (YoY) | +32.0% |
| Profit growth (YoY) | +42.5% |
| Return on equity | 25.2% |
| ROCE | 33.1% |
| Debt / equity | 0.26 |
| Current ratio | 1.90 |
| Free cash flow | ₹5,491 cr |
| Piotroski F-score | 8 / 9 |
| Average daily turnover (50 days) | ₹131.2 cr |

## Questions

### What is the P/E ratio of Lupin Limited?

Lupin Limited's trailing P/E is 16.6, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 15 May 2025 its P/E has ranged 15.7–30.8.

### What were Lupin Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Lupin Limited reported revenue of ₹8,277 cr and net profit of ₹1,415 cr (consolidated), filed with the exchange on 6 Aug 2026.

### What is Lupin Limited's ROE?

Return on equity is 25.2% based on the balance sheet dated 31 Mar 2026.

### Does Lupin Limited have debt?

Debt-to-equity is 0.26 on the balance sheet dated 31 Mar 2026.

### What is LUPIN's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, LUPIN traded between ₹1,892.90 and ₹2,529.50.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/LUPIN

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._